Interferences in immunoassays: review and practical algorithm

L Wauthier, M Plebani, J Favresse - Clinical Chemistry and …, 2022 - degruyter.com
Immunoassays are currently the methods of choice for the measurement of a large panel of
complex and heterogenous molecules owing to full automation, short turnaround time, high …

[HTML][HTML] Assay of thyroid hormones and related substances

CA Spencer - 2015 - europepmc.org
This chapter reviews how improvements in sensitivity and specificity of thyroid function tests
[total and free thyroid hormones, TSH, thyroid autoantibodies (TRAb, TPOAb and TgAb) and …

Pre-existing antibody: biotherapeutic modality-based review

B Gorovits, A Clements-Egan, M Birchler, M Liang… - The AAPS journal, 2016 - Springer
Pre-existing antibodies to biotherapeutic drugs have been detected in drug-naïve subjects
for a variety of biotherapeutic modalities. Pre-existing antibodies are immunoglobulins that …

2015 White Paper on recent issues in bioanalysis: focus on new technologies and biomarkers (Part 3–LBA, biomarkers and immunogenicity)

L Amaravadi, A Song, H Myler, T Thway, S Kirshner… - Bioanalysis, 2015 - Taylor & Francis
The 2015 9th Workshop on Recent Issues in Bioanalysis (9th WRIB) took place in Miami,
Florida with participation of 600 professionals from pharmaceutical and biopharmaceutical …

Intact Free Prostate-Specific Antigen and Free and Total Human Glandular Kallikrein 2. Elimination of Assay Interference by Enzymatic Digestion of Antibodies to F (ab …

V Väisänen, MT Peltola, H Lilja, M Nurmi… - Analytical …, 2006 - ACS Publications
Various blood constituents can interfere with immunoassays, usually by binding the Fc
portion of antibodies. Our previously developed assays for intact free prostate-specific …

Rheumatoid factor and falsely elevated results in commercial immunoassays: data from an early arthritis cohort

JE Gehin, RA Klaasen, ES Norli, DJ Warren… - Rheumatology …, 2021 - Springer
The aim of the study was to assess RF cross-reactivity to animal antibodies used in
immunoassays, and to test if selected commercial immunoassays are vulnerable to …

Heterophilic antibody interference in commercial immunoassays; a screening study using paired native and pre-blocked sera

N Bolstad, DJ Warren, J Bjerner, G Kravdal… - Clinical Chemistry and …, 2011 - degruyter.com
Background: Heterophilic antibodies are still an important source of interference in
immunoassays. We have conducted a screening study for interference in a panel of …

[HTML][HTML] Comparison of ELISA and HPLC-MS methods for the determination of exenatide in biological and biotechnology-based formulation matrices

AR Pinho, A Fortuna, A Falcão, AC Santos… - Journal of …, 2019 - Elsevier
The development of biotechnology-based active pharmaceutical ingredients, such as GLP-1
analogs, brought changes in type 2 diabetes treatment options. For better therapeutic …

Amelioration of heterophile antibody immunosensor interference

JLE Campbell, JE Omakor - US Patent 8,084,272, 2011 - Google Patents
The invention is directed to methods and devices for reducing interference from heterophile
antibodies in an analyte immunoassay. In one embodiment, the invention is to a method …

Overcoming non-specific binding to measure the active concentration and kinetics of serum anti-HLA antibodies by surface plasmon resonance

J Visentin, L Couzi, C Dromer, M Neau-Cransac… - Biosensors and …, 2018 - Elsevier
Human leukocyte antigen (HLA) donor-specific antibodies are key serum biomarkers for
assessing the outcome of transplanted patients. Measuring their active concentration, ie the …